PPCB ▼ -15.6% - Propanc Biopharma, Inc. $PPCB - CORRECTION -- Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans 22-OCT-2026 04:24 PM ET